Compile Data Set for Download or QSAR
Report error Found 39 Enz. Inhib. hit(s) with all data for entry = 10008
TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507657BDBM507657(US11046682, Compound 23)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507658BDBM507658(US11046682, Compound 24)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507663BDBM507663(US11046682, Compound 32)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507665BDBM507665(US11046682, Compound 34)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507666BDBM507666(US11046682, Compound 35)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507667BDBM507667(US11046682, Compound 37)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507669BDBM507669(US11046682, Compound 41)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507670BDBM507670(US11046682, Compound 42)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507671BDBM507671(US11046682, Compound 45)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507672BDBM507672(US11046682, Compound 47)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507673BDBM507673(US11046682, Compound 48)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507674BDBM507674(US11046682, Compound 49)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507675BDBM507675(US11046682, Compound 50)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507676BDBM507676(US11046682, Compound 51)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507677BDBM507677(US11046682, Compound 52)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507678BDBM507678(US11046682, Compound 53)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507649BDBM507649(US11046682, Compound 14)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507684BDBM507684(US11046682, Compound 62)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507652BDBM507652(US11046682, Compound 17)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507653BDBM507653(US11046682, Compound 19)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507654BDBM507654(US11046682, Compound 20)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507656BDBM507656(US11046682, Compound 22)
Affinity DataIC50: 250nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507659BDBM507659(US11046682, Compound 27)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507660BDBM507660(US11046682, Compound 28)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507661BDBM507661(US11046682, Compound 29)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507662BDBM507662(US11046682, Compound 30)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507664BDBM507664(US11046682, Compound 33)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507668BDBM507668(US11046682, Compound 40)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507679BDBM507679(US11046682, Compound 54)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507647BDBM507647(US11046682, Compound 1)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507680BDBM507680(US11046682, Compound 55)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507648BDBM507648(US11046682, Compound 3)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507681BDBM507681(US11046682, Compound 58)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507682BDBM507682(US11046682, Compound 59)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507650BDBM507650(US11046682, Compound 15)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507683BDBM507683(US11046682, Compound 61)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507651BDBM507651(US11046682, Compound 16)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507685BDBM507685(US11046682, Compound 63B:)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 507655BDBM507655(US11046682, Compound 21)
Affinity DataIC50: 875nMAssay Description:The effects of the compounds of the invention on the activity of indoleamine 2,3-dioxygenase (IDO) were evaluated by the Ehrlich method.The experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent